Search Results
You are looking at 1-10 of 80
![Figure 2.](/view/journals/anpr/70/2/inline-i1878-7177-70-2-93-f02.png)
Management of Anaphylaxis in the Dental Office
Anaphylaxis should be recognized at an early stage, epinephrine should be administered intramuscularly, and the patient should be transported immediately to a hospital.
*Implement steps 3–5 promptly and simultaneously. 1
![Figure 1.](/view/journals/anpr/58/4/inline-i0003-3006-58-4-166-f01.png)
Pharmacokinetic considerations. The concentration of drug at the target tissue is determined by combined influences of absorption, metabolism, distribution, and elimination (excretion). Notice obstacles to bioavailability (serum concentration) following oral and intramuscular administration compared to those following intravenous administration.
![Figure 1.](/view/journals/anpr/53/4/inline-i0003-3006-53-4-140-f01.gif)
Drug absorption. Following oral (PO) or topical administration, a drug requires lipid solubility in order to diffuse through the epithelium to reach the capillaries. When administered by intramuscular (IM) or subcutaneous (SC) injection, lipid solubility is not required to reach the capillaries. Once absorbed following PO administration, a drug must travel through the portal system to liver before reaching systemic circulation (venae cavae). See text for further explanation.
![Figure 2.](/view/journals/anpr/58/4/inline-i0003-3006-58-4-166-f02.png)
Time-concentration curves for meperidine. This graph illustrates time-concentration curves for identical doses of meperidine following 3 routes of administration. Following intravenous (IV) administration the concentration drops rapidly during the first 30 minutes due to distribution. The decline then becomes more gradual as drug is eliminated. Following intramuscular (IM) and oral (PO) administration the serum level rises gradually as drug is absorbed and distributed simultaneously. The peak is lower than that following IV administration as initial drug absorbed undergoes distribution and possible elimination before final amounts are absorbed. Compared to IM administration, the time until peak concentration following a PO dose is longer due to slower absorption, and the peak is lower due to more factors hindering bioavailability, eg, first-pass metabolism. Notice that once the processes of absorption and distribution are completed, elimination of drug occurs at an identical rate regardless of the route by which it was administered; elimination T1/2 is identical (adapted from Stambaugh et al2).